Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma
- PMID: 10551410
- DOI: 10.1111/j.1600-0560.1999.tb01862.x
Syndecan-1 expression is diminished in acantholytic cutaneous squamous cell carcinoma
Abstract
Syndecan-1 is a cell surface proteoglycan predominantly expressed on the surface of adult epithelial cells, and is normally present in all epidermal layers except for the most superficial terminally differentiated cells. Syndecan-1 mediates cell-cell and cell-extracellular matrix adhesion, thereby influencing cell morphology and growth characteristics. In addition, in vitro studies have shown that expression of syndecan-1 on tumor cells inhibits their invasion into the extracellular matrix. A total of 23 cutaneous biopsies of squamous cell carcinoma, including acantholytic squamous cell carcinoma, invasive squamous cell carcinoma which was not acantholytic, and squamous cell carcinoma in situ were examined for syndecan-1 immunoreactivity. The level of syndecan-1 expression was related to the degree of squamous cell dyshesion, with expression being greatest in the in situ lesions and least in the acantholytic lesions. The loss of syndecan-1 expression with increasing dyshesion of squamous cell carcinoma may be a mechanism for loosening of intercellular and cell-extracellular matrix attachments, thereby promoting the invasion of neoplastic cells into the dermis.
Similar articles
-
The expression of syndecan-1 is preferentially reduced compared with that of E-cadherin in acantholytic squamous cell carcinoma.J Cutan Pathol. 2001 Feb;28(2):83-9. doi: 10.1034/j.1600-0560.2001.280204.x. J Cutan Pathol. 2001. PMID: 11168756
-
The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma.Mod Pathol. 2002 Jan;15(1):45-9. doi: 10.1038/modpathol.3880488. Mod Pathol. 2002. PMID: 11796840
-
Syndecan-1 expression is decreased with increasing aggressiveness of basal cell carcinoma.Am J Dermatopathol. 2000 Apr;22(2):119-22. doi: 10.1097/00000372-200004000-00005. Am J Dermatopathol. 2000. PMID: 10770430
-
The role of syndecan-1 in malignancies.Ann Med. 1996 Feb;28(1):63-7. doi: 10.3109/07853899608999076. Ann Med. 1996. PMID: 8932508 Review.
-
Morphologic mimicry: acantholytic squamous cell carcinoma in nondermal locations-a literature review.Ann N Y Acad Sci. 2018 Dec;1434(1):102-108. doi: 10.1111/nyas.13675. Epub 2018 May 9. Ann N Y Acad Sci. 2018. PMID: 29744885 Review.
Cited by
-
Matrix Effectors in the Pathogenesis of Keratinocyte-Derived Carcinomas.Front Med (Lausanne). 2022 Apr 29;9:879500. doi: 10.3389/fmed.2022.879500. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35572966 Free PMC article. Review.
-
Squamous cell carcinoma with rhabdoid features of the gingiva: a case report with unusual histology.Med Mol Morphol. 2014 Dec;47(4):240-5. doi: 10.1007/s00795-013-0066-4. Epub 2013 Dec 27. Med Mol Morphol. 2014. PMID: 24370546
-
Loss of syndecan-1 is associated with malignant conversion in skin carcinogenesis.Mol Carcinog. 2010 Apr;49(4):363-73. doi: 10.1002/mc.20609. Mol Carcinog. 2010. PMID: 20082322 Free PMC article.
-
Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas.Jpn J Cancer Res. 2001 Oct;92(10):1062-73. doi: 10.1111/j.1349-7006.2001.tb01061.x. Jpn J Cancer Res. 2001. PMID: 11676857 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
